Psychedelic Drugs Market CAGR at +13.3% with Analysis of Growing Technology Trends, Industry Research, Future Growth and Size, Projection by 2028

·11 min read

SAN FRANCISCO, July 14, 2021 (GLOBE NEWSWIRE) -- Psychedelic Drugs Market Research Report gives insightful analysis of the market along with its comprehensive understanding and its commercial landscape. The report offers market share appraisals for regional and global levels. It gives detailed overview of the parent market. The report contains information about key drivers, restraints, opportunities, and their impact analysis on the market size. Psychedelic Drugs Market study provides an in-depth analysis of the global order management software market and current & future trends to elucidate imminent investment pockets. It analyses and forecasts Psychedelic Drugs Market on the basis of type, function and application.

The psychedelic drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 13.3% in the forecast period of 2021 to 2028 and is expected to reach USD 7,567.52 million by 2028 from USD 2,823.67 million in 2020. The rising prevalence of mental depression and anxiety and availability of off-label drugs are the major drivers which have propelled the demand of the psychedelic drugs market in the forecast period.

Get Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-psychedelic-drugs-market

The universal Psychedelic Drugs Market Report provides industry chain suppliers of the market with contact information. It includes potential and niche segments/regions exhibiting promising growth. Under market development, it gives comprehensive information about emerging markets and also analyses the market across geographies. It gives comprehensive overview of the Psychedelic Drugs Market. The report contains information about the top players in this industry, their product portfolios, and their key strategies.

Psychedelic drugs involve various types of chemical substances including LSD and chemical extracted from plants. Psychedelic drugs have the ability to change or enhance the sensory perceptions, thought processes, energy levels and have also been reported to facilitate spiritual experiences. Psychedelic drugs can be categorized into empathogens and dissociative drugs (such as PCP) and serotonergic (classic hallucinogens) such as LSD.

Scope of the Global Psychedelic Drugs Market:
All country-based analysis of global psychedelic drugs market is further analysed based on further segmentation. On the basis of source, the psychedelic drugs market is segmented into synthetic and natural. On the basis of type, the psychedelic drugs market is segmented into dissociatives, empathogens and others. On the basis of drugs, the psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others. On the basis of application, the psychedelic drugs market is segmented into narcolepsy, treatment resistant depression, post-traumatic stress disorder, major depressive disorder, opiate addiction and others. On the basis of route of administration, the psychedelic drugs market is segmented into oral, inhalation and injectable. On the basis of end user, the psychedelic drugs market is segmented into hospitals, specialty clinics, homecare and others. On the basis of distribution channel, the psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy.

Competitive Analysis of Psychedelic Drugs Market:
The psychedelic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the company’s focus.

Know More Information like Facts and Figures of Global Psychedelic Drugs Market Report @ https://www.databridgemarketresearch.com/reports/global-psychedelic-drugs-market

Psychedelic Drugs Market Key Competitors:
The major players covered in the report are

  • Jazz Pharmaceuticals, Inc.

  • Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)

  • Pfizer Inc.

  • Verrian

  • Avadel

  • Celon Pharma S.A.

  • COMPASS

  • F. Hoffmann-La Roche Ltd

  • Hikma Pharmaceuticals PLC

  • NeuroRx, Inc.

  • PharmaTher Inc.

  • usonainstitute.org

Access Full Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/global-psychedelic-drugs-market

Segmentation: Global Psychedelic Drugs Market:

  • On the basis of source, the psychedelic drugs market is segmented into synthetic and natural. In 2021, synthetic segment is dominating as most of the products are made from chemicals that are man-made with very few products such as psilocybin made from natural ingredients.

  • On the basis of type, the psychedelic drugs market is segmented into dissociatives, empathogens and others. In 2021, empathogens segment produce experiences of emotional communion, oneness, relatedness and used for treatment of cataplexy, narcolepsy and related disorders.

  • On the basis of drugs, the psychedelic drugs market is segmented into gamma-hydroxybutyric acid, ketamine, psilocybin and others. In 2021, gamma-hydroxybutyric acid segment is dominating as xyrem from Jazz Pharmaceutical is one of the oldest available psychedelic drugs available in the market holding a major share and belongs to the drug class.

  • On the basis of application, the psychedelic drugs market is segmented into narcolepsy, treatment resistant depression, post-traumatic stress disorder, major depressive disorder, opiate addiction and others. In 2021, narcolepsy segment is dominating as xyrem from Jazz Pharmaceutical is used for its treatment and it is the major shareholder in the market.

  • On the basis of route of administration, the psychedelic drugs market is segmented into oral, inhalation and injectable. In 2021, oral segment is dominating as it is preferred over the various other administration routes of drug delivery.

  • On the basis of end user, the psychedelic drugs market is segmented into hospitals, specialty clinics, homecare and others. In 2021, hospitals segment dominates the psychedelic drugs market due to the high patient load and most of the drugs are given under doctors’ supervision.

  • On the basis of distribution channel, the psychedelic drugs market is segmented into hospitals pharmacy, retail pharmacy and online pharmacy. In 2021, hospitals pharmacy segment holds the largest market share as a larger number of patients are treated in hospitals and the demand for medicines in hospital pharmacy increases.

Speak to Report Author @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-psychedelic-drugs-market

Some of the Major Highlights of TOC covers: Global Psychedelic Drugs Market

LIST OF TABLES

  • TABLE 1 U.S. PSYCHEDELIC DRUGS MARKET, COMPANY WISE PIPELINE ANALYSIS

  • TABLE 2 U.S. PSYCHEDELIC DRUGS MARKET, RESEARCH INSTITUTE PIPELINE ANALYSIS

  • TABLE 3 PSYCHEDELICS RESEARCHES, IN EUROPE

  • TABLE 4 MENTAL ILLNESS IN THE U.S. ADULTS, IN 2018

  • TABLE 5 MENTAL DISORDERS, IN THE U.S. ADULTS, IN 2018

  • TABLE 6 MORE THAN ONE IN SIX PEOPLE IN EU COUNTRIES HAVE A MENTAL HEALTH PROBLEM

  • TABLE 7 MEN ARE MORE LIKELY TO DIE FROM SUICIDE, IN ALL EU COUNTRIES

  • TABLE 8 MENTAL DISORDERS CAUSED BY USAGE OF SUBSTANCE DISORDERS, IN WORLD, IN 2017

  • TABLE 9 DRUG DEVELOPMENT PATHWAY FOR FDA APPROVAL OF NEW MEDICATIONS

  • TABLE 10 THE 1971 UN CONVENTION ON PSYCHOTROPIC SUBSTANCES

  • TABLE 11 COST OF PSYCHEDELIC DRUGS

  • TABLE 12 TOTAL COSTS (DIRECT AND INDIRECT) OF MENTAL HEALTH PROBLEMS IN EU COUNTRIES, IN MILLION AND AS A SHARE OF GDP, IN 2015

  • TABLE 13 PSYCHEDELIC DRUGS R&D ACTIVITIES

  • TABLE 14 GLOBAL PSYCHEDELIC DRUG MARKET, BY SOURCE 2020-2028 (USD MILLION)

  • TABLE 15 GLOBAL SYNTHETIC IN PSYCHEDELIC DRUGS MARKET, BY REGION, 2019-2028 (USD MILLION)

Continue...
Get Free Detailed Tables of Contents with Respective images and Pie chart of This Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-psychedelic-drugs-market
LIST OF FIGURES:

  • FIGURE 1 GLOBAL PSYCHEDELIC DRUGS MARKET: SEGMENTATION

  • FIGURE 2 GLOBAL PSYCHEDELIC DRUGS MARKET: DATA TRIANGULATION

  • FIGURE 3 GLOBAL PSYCHEDELIC DRUGS MARKET: DROC ANALYSIS

  • FIGURE 4 GLOBAL PSYCHEDELIC DRUGS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

  • FIGURE 5 GLOBAL PSYCHEDELIC DRUGS MARKET: COMPANY RESEARCH ANALYSIS

  • FIGURE 6 GLOBAL PSYCHEDELIC DRUGS MARKET: MULTIVARIATE MODELLING

  • FIGURE 7 GLOBAL PSYCHEDELIC DRUGS MARKET: INTERVIEW DEMOGRAPHICS

  • FIGURE 8 GLOBAL PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID

  • FIGURE 9 GLOBAL PSYCHEDELIC DRUGS MARKET: MARKET APPLICATION COVERAGE GRID

  • FIGURE 10 GLOBAL PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS

Continue...

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia. Email us at sopan.gedam@databridgemarketresearch.com

Key Offerings:

  • Market Size & Forecast by Revenue | 2021−2028

  • Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities

  • Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography

  • Competitive Landscape – Top key vendors and other prominent vendors

If Looking for Customization or any Doubt to Reach to us at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-psychedelic-drugs-market

Reason to Get This Report?

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Psychedelic Drugs Market

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the Psychedelic Drugs Market, thereby allowing players to develop effective long term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Trending Related Reports

  • Dermatology Drugs Market, By Dermatological Diseases (Acne, Dermatitis, Psoriasis, Skin Cancer, Others), Prescription mode (Prescription Based Drugs, Over Counter Drugs), Drug Classification (Corticosteroids, Astringents, Anti-Inflammatory & Antipruritic Drugs, Anti-Infective/Antibacterial Drugs, Antifungal Drugs), Route Of Administration (Topical, Oral, Parenteral Administration), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Speciality Clinics, Cosmetic Centres), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028. https://www.databridgemarketresearch.com/reports/global-dermatology-drugs-market

  • Orphan Drugs Market, By Drug Type (Biological, Non-Biological), Disease Type (Oncologic Diseases, Metabolic Disease, Hematologic And Immunologic Diseases, Infectious Diseases, Neurological Diseases, Others), Indication Type (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Renal Cell Carcinoma, Graft Vs Host Disease, Others), Drug Type (Revlimid, Rituxan, Opdivo, Keytruda, Imbruvica, Soliris, Jakaf, Pomalyst, Darzalex, Spinraza, Adcetris), Sale (Generics, Prescribed), Therapy Class (Oncology, Blood, Central Nervous Systems, Endocrine, Cardiovascular, Respiratory), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028. https://www.databridgemarketresearch.com/reports/global-orphan-drugs-market

  • Performance Enhancing Drugs Market, By Type (Ergogenic Aids, Nootropic and Others), Products (Pills, Injections, Patches and Others), End User (Athletes, Body Builders, Students, Militaries and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027. https://www.databridgemarketresearch.com/reports/global-performance-enhancing-drugs-market

  • Migraine Drugs Market, By Product Type ( Acute Migraine Treatment, Preventive Migraine Treatment), Route of Administration (Oral, Injection, Others), End User (Hospitals Based Pharmacies, Retail Pharmacies, Online Pharmacies), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2027. https://www.databridgemarketresearch.com/reports/global-migraine-drugs-market

About Us:
An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge is adept at creating satisfied clients who reckon upon our services and rely on our hard work with certitude.
We are content with our glorious 99.9 % client satisfying rate.

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email - Corporatesales@databridgemarketresearch.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting